144 related articles for article (PubMed ID: 10780766)
1. Exhaled nitric oxide in asthmatic children exposed to relevant allergens: effect of flunisolide.
Piacentini GL; Bodini A; Costella S; Vicentini L; Mazzi P; Suzuki Y; Peroni D; Boner AL
Eur Respir J; 2000 Apr; 15(4):730-4. PubMed ID: 10780766
[TBL] [Abstract][Full Text] [Related]
2. Effect of montelukast on exhaled NO in asthmatic children exposed to relevant allergens.
Piacentini GL; Peroni DG; Del Giudice MM; Bodini A; Costella S; Vicentini L; Boner AL
Pediatr Allergy Immunol; 2002 Apr; 13(2):137-9. PubMed ID: 12000487
[TBL] [Abstract][Full Text] [Related]
3. e-NO peak versus e-NO plateau values in evaluating e-NO production in steroid-naive and in steroid-treated asthmatic children and in detecting response to inhaled steroid treatment.
Silvestri M; Spallarossa D; Battistini E; Fregonese B; Rossi GA
Pediatr Pulmonol; 2001 Jan; 31(1):37-43. PubMed ID: 11180673
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent changes in orally exhaled nitric oxide and pulmonary functions induced by inhaled corticosteroids in childhood asthma.
Spallarossa D; Battistini E; Silvestri M; Sabatini F; Biraghi MG; Rossi GA
J Asthma; 2001 Oct; 38(7):545-53. PubMed ID: 11714077
[TBL] [Abstract][Full Text] [Related]
5. Flunisolide decreases exhaled nitric oxide and nitrotyrosine levels in asthmatic children.
Bodini A; Peroni DG; Zardini F; Corradi M; Alinovi R; Boner AL; Piacentini GL
Mediators Inflamm; 2006; 2006(4):31919. PubMed ID: 17047290
[TBL] [Abstract][Full Text] [Related]
6. Exhaled nitric oxide in children with asthma receiving Xolair (omalizumab), a monoclonal anti-immunoglobulin E antibody.
Silkoff PE; Romero FA; Gupta N; Townley RG; Milgrom H
Pediatrics; 2004 Apr; 113(4):e308-12. PubMed ID: 15060258
[TBL] [Abstract][Full Text] [Related]
7. Effects of house dust mite avoidance measures on Der p 1 concentrations and clinical condition of mild adult house dust mite-allergic asthmatic patients, using no inhaled steroids.
Cloosterman SG; Schermer TR; Bijl-Hofland ID; Van Der Heide S; Brunekreef B; Van Den Elshout FJ; Van Herwaarden CL; Van Schayck CP
Clin Exp Allergy; 1999 Oct; 29(10):1336-46. PubMed ID: 10520054
[TBL] [Abstract][Full Text] [Related]
8. Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children.
Ghiro L; Zanconato S; Rampon O; Piovan V; Pasquale MF; Baraldi E
Eur Respir J; 2002 Sep; 20(3):630-4. PubMed ID: 12358339
[TBL] [Abstract][Full Text] [Related]
9. Comparison of high-dose inhaled flunisolide to systemic corticosteroids in severe adult asthma.
Lee-Wong M; Dayrit FM; Kohli AR; Acquah S; Mayo PH
Chest; 2002 Oct; 122(4):1208-13. PubMed ID: 12377843
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of FeNO response to inhaled steroid in asthmatic children.
Buchvald F; Eiberg H; Bisgaard H
Clin Exp Allergy; 2003 Dec; 33(12):1735-40. PubMed ID: 14656363
[TBL] [Abstract][Full Text] [Related]
11. Exhaled nitric oxide daily evaluation is effective in monitoring exposure to relevant allergens in asthmatic children.
Bodini A; Peroni D; Loiacono A; Costella S; Pigozzi R; Baraldi E; Boner AL; Piacentini GL
Chest; 2007 Nov; 132(5):1520-5. PubMed ID: 17890466
[TBL] [Abstract][Full Text] [Related]
12. Effect of budesonide and montelukast in asthmatic children exposed to relevant allergens.
Peroni D; Bodini A; Miraglia Del Giudice M; Loiacono A; Baraldi E; Boner AL; Piacentini G
Allergy; 2005 Feb; 60(2):206-10. PubMed ID: 15647042
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of inhaled flunisolide versus placebo among asthmatic patients discharged from the emergency department.
Brenner BE; Chavda KK; Camargo CA
Ann Emerg Med; 2000 Nov; 36(5):417-26. PubMed ID: 11054193
[TBL] [Abstract][Full Text] [Related]
14. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients.
Casale TB; Nelson HS; Stricker WE; Raff H; Newman KB
Ann Allergy Asthma Immunol; 2001 Nov; 87(5):379-85. PubMed ID: 11730179
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of once-daily dosing of inhaled flunisolide in maintaining asthma control.
ZuWallack RL; Rosen JP; Cohen L; Rachelefsky GS; Gong H; Goldsobel AB; Kaliner MA; White MV; Bronsky EA; Chervinsky P; Lotner GZ; Corren J; Bodenheimer S
J Allergy Clin Immunol; 1997 Mar; 99(3):278-85. PubMed ID: 9058681
[TBL] [Abstract][Full Text] [Related]
16. Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients.
Corren J; Nelson H; Greos LS; Bensch G; Goldstein M; Wu J; Wang S; Newman K
Ann Allergy Asthma Immunol; 2001 Nov; 87(5):405-11. PubMed ID: 11730183
[TBL] [Abstract][Full Text] [Related]
17. Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma.
Sorkness CA; LaForce C; Storms W; Lincourt WR; Edwards L; Rogenes PR
Clin Ther; 1999 Feb; 21(2):353-67. PubMed ID: 10211538
[TBL] [Abstract][Full Text] [Related]
18. Asthma, atopy and exhaled nitric oxide in a cohort of 6-yr-old New Zealand children.
Crane J; Lampshire P; Wickens K; Epton M; Siebers R; Ingham T; Pattemore P; Town I;
Pediatr Allergy Immunol; 2012 Feb; 23(1):59-64. PubMed ID: 22104032
[TBL] [Abstract][Full Text] [Related]
19. Double-blind evaluation of effectiveness and safety of flunisolide aerosol for treatment of bronchial asthma in children.
Piacentini GL; Sette L; Peroni DG; Bonizzato C; Bonetti S; Boner AL
Allergy; 1990 Nov; 45(8):612-6. PubMed ID: 2288396
[TBL] [Abstract][Full Text] [Related]
20. Treatment with inhaled flunisolide.
Edmonds ML; Rowe BH
Chest; 2004 May; 125(5):1961-2; author reply 1962-3. PubMed ID: 15136418
[No Abstract] [Full Text] [Related]
[Next] [New Search]
